Home  »  Finance   »  Can Viking Therapeutics Inc. Bounce Back? 52-Week ...

Can Viking Therapeutics Inc. Bounce Back? 52-Week Performance and Analyst Predictions

Viking Therapeutics Inc. (VKTX) has a current stock price of $22.78. During the previous trading session, the stock witnessed a notable rise, reaching a high of $25.7199 after opening at $24.48. The stock’s low for the day was $22.65, and it eventually closed at $24.35.

Viking Therapeutics Inc.’s stock market performance has been consistent. The 1-year high for the company’s stock was recorded at $25.03 on 05/23/23, with the lowest value being $2.02 on 06/16/22.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.


52-week price history of VKTX Stock

A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Viking Therapeutics Inc.’s current trading price is -8.99% away from its 52-week high, while its distance from the 52-week low is 1027.72%. The stock’s price range during this period has fluctuated between $2.02 and $25.03. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 3.87 million for the day, which was evidently lower than the average daily volume of 4.84 million over the last three months.

Financial Performance and Market Capitalization

Viking Therapeutics Inc. (VKTX) has experienced a quarterly rise of 107.28% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.30B and boasts a workforce of 22 employees.

Analysts’ Ratings For Viking Therapeutics Inc.

As of right now, 9 analysts are rating Viking Therapeutics Inc. as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 14.08, with a change in price of +13.79. Similarly, Viking Therapeutics Inc. recorded 3,746,108 in trading volume during the last 100 days, posting a change of +153.39%.

VKTX Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VKTX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

VKTX Stock Stochastic Average

Viking Therapeutics Inc.’s raw stochastic average for the past 50 days is currently at 82.75%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 54.91%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 69.30% and 72.39%, respectively.

VKTX Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price gain of 142.34% this year. Over the last six months, there has been a weaker performance of 469.50%. The price of VKTX fallen by 6.80% during the last 30 days period. For the last 5-days stocks have slided -7.57%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts